How many clinical trials are tracked of buprenorphine-naloxone?

21 trials are tracked, 4 with published results.

Mode

All Infectious Disease Oncology Neurology Cardiology Psychiatry Diabetes & Endocrinology Pediatrics Allergy & Immunology Rheumatology Gastroenterology Primary Care & Family Medicine Nutrition & Obesity Medicine OB/GYN & Women's Health Orthopedics & Sports Medicine Genetics & Precision Medicine Radiology & Imaging Pulmonology & Critical Care Anesthesiology & Pain Medicine Physical Medicine & Rehab Nephrology Hematology Dermatology Urology Emergency Medicine Ophthalmology Geriatrics & Aging ENT (Otolaryngology) Palliative Care

Research

Clinical Trials Drug Pipeline Weekly Digests

Reference

Conditions Medications

Community

Questions

Text Size

buprenorphine-naloxone

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of buprenorphine-naloxone

21 trials tracked of buprenorphine-naloxone: 10 in phase 3 or 4 and 4 with published results. The most-cited published study has 121 citations.

21Trials tracked

10Phase 3 & 4

0Recruiting

4With published results

Phase distribution

Phase 4 8 Phase 3 2 Phase 2 5 Phase 1 3 Other / NA 3

Phase 4 Starting Treatment With Agonist Replacement Therapies (START) Completed · 121 cited
Phase 4 Buprenorphine and Methadone for Opioid-dependent Chronic Back Pain Patients Completed · 47 cited
Phase 4 Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment Completed · 47 cited
Phase 4 Buprenorphine to Improve HIV Care Engagement and Outcomes Completed · 20 cited
Phase 4 Rapid Initiation of Drug Treatment Engagement Completed
Phase 4 Buprenorphine Loading in the Emergency Department Completed

Show 15 more trials

Phase 4 Preference for Subutex® (Buprenorphine) Versus Suboxone® (Buprenorphine/Naloxone) in Opioid Dependent Patients on Subutex® (Study P05094)(COMPLETED) Completed
Phase 4 Buprenorphine and Methadone for Opioid Dependent Chronic Pain Patients Completed
Phase 3 Dane County Drug Court Study for Addicted Offenders Completed
Phase 3 Buprenorphine/Naloxone Stabilization and Induction Onto Injection Naltrexone Completed
Phase 2 Low Dose Naltrexone-buprenorphine Transfer to Vivitrol Injection in Opioid Dependence Completed
Phase 2 Maternal Buprenorphine-naloxone Treatment and the Infant Completed
Phase 2 Drug-drug Interaction Study of Lemborexant as an Adjunctive Treatment for Buprenorphine/Naloxone for Opioid Use Disorder Completed
Phase 2 Veterans' Pain Care Organizational Improvement Comparative Effectiveness Study Completed
Phase 2 Medications Development for Drug Abuse Disorders Completed
Phase 1 Buprenorphine Physician-Pharmacist Collaboration in the Management of Patients With Opioid Use Disorder: CTN 0075 Completed
Phase 1 A Study to Assess the Effect of a Single Dose of ASP8062 on the Multiple Dose Safety, Tolerability and Pharmacokinetics of Buprenorphine/Naloxone in Participants With Opioid Use Disorder Completed
Phase 1 A Study to Evaluate the Pharmacokinetic Effect of SCH 503034 (Boceprevir) on Methadone or Buprenorphine/Naloxone Plasma Concentrations (P08123) Completed
N/A Treatment of Opioid Dependent Patients With Suboxone: Acceptability & Safety Data From Real Life Scenario (Study P05603) Completed
N/A Acceptability and Safety of Switching From Subutex or Other Opioid Drug Dependence Therapy to Suboxone (NIS P05444) Completed
N/A HIV, Buprenorphine, and the Criminal Justice System Completed

Showing the 21 most-cited and recently-updated of 21 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.